We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Listing...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 06 nov...
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext...
Cellectis présente de multiples stratégies pour améliorer l'efficacité des cellules CAR T dans les tumeurs solides à la réunion annuelle de la SITC NEW YORK, 05 nov. 2024 (GLOBE NEWSWIRE...
Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 UCART22 and UCART20x22: enrollment ongoing, Phase 1 dataset and late-stage development strategy to be presented in...
Cellectis présente ses résultats financiers du troisième trimestre 2024 et une mise à jour de ses activités UCART22 et UCART20x22 : recrutement de patients en cours, un ensemble de données de la...
Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024 NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a...
Cellectis publiera ses résultats financiers du troisième trimestre 2024 le 4 novembre 2024 NEW YORK, 30 oct. 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société...
Cellectis présentera des données sur des TALE Base Editors ainsi que sur son programme de thérapie génique non-virale lors du 31ème congrès annuel de l’ESGCT NEW YORK, 22 oct. 2024 (GLOBE...
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.108 | 6.25 | 1.728 | 1.782 | 1.69 | 758 | 1.70804065 | DE |
4 | 0.06 | 3.37837837838 | 1.776 | 1.8 | 1.684 | 744 | 1.7107346 | DE |
12 | -0.1739999 | -8.65671187347 | 2.0099999 | 2.17 | 1.684 | 934 | 1.83345262 | DE |
26 | -0.834 | -31.2359550562 | 2.67 | 2.79 | 1.636 | 1688 | 1.9983438 | DE |
52 | -0.634 | -25.6680161943 | 2.47 | 3.39 | 1.636 | 2821 | 2.48437664 | DE |
156 | -0.123 | -6.2787136294 | 1.959 | 3.39 | 0.936 | 4734 | 2.49660158 | DE |
260 | -0.123 | -6.2787136294 | 1.959 | 3.39 | 0.936 | 4734 | 2.49660158 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions